Phase III trial
Showing 9976 - 10000 of >10,000
Autism Spectrum Disorder Trial in Phoenix (Wide-spectrum nutritional supplement, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Wide-spectrum nutritional supplement
- Placebo
-
Phoenix, ArizonaSouthwestern Research & Resource Center
Sep 26, 2022
Viral and Epigenetic Influences in CRSwNP
Recruiting
- Chronic Rhinosinusitis (Diagnosis)
- Endoscopic sinus surgery (ESS)
-
Montréal, Quebec, CanadaCHUM
May 19, 2023
Premature Birth, Parenteral Nutrition, Motor Disorders Trial in Almería (Neurodevelopmental stimulation + Oral stimulation, Oral
Enrolling by invitation
- Premature Birth
- +4 more
- Neurodevelopmental stimulation + Oral stimulation
- Oral stimulation
-
Almería, SpainUniversity Hospital Torrecardenas
Nov 8, 2022
Brain Tumor, Metabolic Disturbance, Inflammatory Response Trial in Thessaloniki (Dexmedetomidine, Normal saline)
Completed
- Brain Tumor
- +3 more
- Dexmedetomidine
- Normal saline
-
Thessaloniki, GreeceAHEPA University Hospital
Feb 14, 2022
Danon Disease Trial in La Jolla, Philadelphia (RP-A501)
Recruiting
- Danon Disease
- RP-A501
-
La Jolla, California
- +1 more
Oct 17, 2023
SARS-CoV-2 Infection Trial in Baltimore (B/HPIV3/S-6P)
Recruiting
- SARS-CoV-2 Infection
- B/HPIV3/S-6P
-
Baltimore, MarylandJohns Hopkins Bloomberg School of Public Health
Aug 30, 2023
Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)
Recruiting
- Hepatocellular Carcinoma
- PM8002
- FOLFOX regimen
-
Hangzhou, Zhejiang, ChinaCancer Hospital of The University of Chinese Academy of Sciences
May 19, 2023
Rhinitis Trial in Muang (Cleanoze®, Saline (Syringe irrigation))
Completed
- Rhinitis
- Cleanoze®
- Saline (Syringe irrigation)
-
Muang, Khonkaen, ThailandDepartment of Otolaryngology, Khonkaen University
Aug 7, 2018
CDED in a Real World IBD Clinic
Recruiting
- Crohn Disease
-
Tel Aviv, Israel
- +1 more
Oct 11, 2022
Bladder Urothelial Carcinoma In Situ, Infiltrating Bladder Mixed Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Guam,
Recruiting
- Bladder Urothelial Carcinoma In Situ
- +4 more
- Gemcitabine Hydrochloride
- Pembrolizumab
-
Birmingham, Alabama
- +379 more
Aug 23, 2022
Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)
Completed
- Acute Myelogenous Leukemia
- AML
-
Kansas City, Kansas
- +8 more
Aug 3, 2022
Ketamine Causing Adverse Effects in Therapeutic Use Trial in Assiut (Ketamine 0.1 mg, Ketamine 0.2 mg, Ketamine 0.3 mg)
Recruiting
- Ketamine Causing Adverse Effects in Therapeutic Use
- Ketamine 0.1 mg
- +2 more
-
Assiut, EgyptAssiut University hospital
Apr 17, 2022
Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Haplo SCT with NK cells
- Haplo SCT
-
Roma, RM, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021
Locally Advanced Unresectable or Metastatic Solid Tumor Trial in China, United States (SIM0237)
Recruiting
- Locally Advanced Unresectable or Metastatic Solid Tumor
-
Indianapolis, Indiana
- +7 more
Mar 10, 2023
GVHD Trial in Worldwide (Begelomab, Conventional Second-line Treatment)
Terminated
- Graft vs Host Disease
- Begelomab
- Conventional Second-line Treatment
-
Duarte, California
- +26 more
Jan 20, 2020
Raynaud Phenomenon Secondary to Systemic Sclerosis Trial in Paris (BOTOX® solution, Placebo group)
Completed
- Raynaud Phenomenon Secondary to Systemic Sclerosis
- BOTOX® solution
- Placebo group
-
Paris, FranceHôpital Tenon
Feb 9, 2022
Paroxysmal Nocturnal Hemoglobinuria Trial in China (Eculizumab)
Not yet recruiting
- Paroxysmal Nocturnal Hemoglobinuria
-
Beijing, China
- +6 more
May 24, 2023
Disfigurement of Face Trial in New York (Face recognition task)
Enrolling by invitation
- Disfigurement of Face
- Face recognition task
-
New York, New YorkNew York University School of Medicine
Sep 7, 2022